134 related articles for article (PubMed ID: 24820259)
1. A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center.
Becker A; Seiler D; Kwiatkowski M; Kluth LA; Schnell D; Graefen M; Schlomm T; Fisch M; Recker F; Weissbach L; Chun FK
World J Urol; 2014 Aug; 32(4):891-7. PubMed ID: 24820259
[TBL] [Abstract][Full Text] [Related]
2. [Patterns of care of patients with localized prostate cancer in Germany: a health care study with focus on active surveillance].
Chun FK; Becker A; Kluth LA; Seiler D; Schnell D; Fisch M; Graefen M; Weissbach L
Urologe A; 2015 Jan; 54(1):6-13. PubMed ID: 25391440
[TBL] [Abstract][Full Text] [Related]
3. Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice.
Herden J; Weissbach L
World J Urol; 2018 Mar; 36(3):383-391. PubMed ID: 29330583
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
[TBL] [Abstract][Full Text] [Related]
5. Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study.
Herden J; Schwarte A; Boedefeld EA; Weissbach L
Urol Int; 2021; 105(5-6):428-435. PubMed ID: 33517336
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study.
Herden J; Schwarte A; Werner T; Behrendt U; Heidenreich A; Weissbach L
World J Urol; 2021 Jul; 39(7):2515-2523. PubMed ID: 33000341
[TBL] [Abstract][Full Text] [Related]
7. Active surveillance in localized prostate cancer: comparison of incidental tumours (T1a/b) and tumours diagnosed by core needle biopsy (T1c/T2a): results from the HAROW study.
Herden J; Wille S; Weissbach L
BJU Int; 2016 Aug; 118(2):258-63. PubMed ID: 26332209
[TBL] [Abstract][Full Text] [Related]
8. The Treatment of Localized Prostate Cancer in Everyday Practice in Germany.
Herden J; Ansmann L; Ernstmann N; Schnell D; Weißbac L
Dtsch Arztebl Int; 2016 May; 113(19):329-36. PubMed ID: 27232362
[TBL] [Abstract][Full Text] [Related]
9. [Treatment costs of localized prostate cancer in Germany : Economic results from the HAROW observational study].
Reinhold T; Dornquast C; Börgermann C; Weißbach L
Urologe A; 2016 Dec; 55(12):1573-1585. PubMed ID: 27822603
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification: a tool to predict the course of active surveillance for localized prostate cancer?
Herden J; Heidenreich A; Weissbach L
BJU Int; 2017 Aug; 120(2):212-218. PubMed ID: 27862832
[TBL] [Abstract][Full Text] [Related]
12. [Noninvasive treatment of organ-confined prostate cancer in elderly patients-results of the HAROW study].
Herden J; Boedefeld EA; Weißbach L
Urologe A; 2020 Apr; 59(4):450-460. PubMed ID: 32025749
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of clinically localized prostate cancer patients managed with initial monitoring approach versus upfront local treatment: a North American population-based study.
Abdel-Rahman O
Clin Transl Oncol; 2019 Dec; 21(12):1673-1679. PubMed ID: 30929179
[TBL] [Abstract][Full Text] [Related]
14. Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center.
Carlsson S; Benfante N; Alvim R; Sjoberg DD; Vickers A; Reuter VE; Fine SW; Vargas HA; Wiseman M; Mamoor M; Ehdaie B; Laudone V; Scardino P; Eastham J; Touijer K
J Urol; 2020 Jun; 203(6):1117-1121. PubMed ID: 31909690
[TBL] [Abstract][Full Text] [Related]
15. [The HAROW study: an example of outcomes research: a prospective, non-interventional study comparing treatment options in localized prostate cancer].
Herden J; Ernstmann N; Schnell D; Weißbach L
Urologe A; 2014 Dec; 53(12):1743-52. PubMed ID: 25412911
[TBL] [Abstract][Full Text] [Related]
16. An evidence review of active surveillance in men with localized prostate cancer.
Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
[TBL] [Abstract][Full Text] [Related]
17. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
[TBL] [Abstract][Full Text] [Related]
18. Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients.
Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
Eur Urol Oncol; 2018 Aug; 1(3):231-237. PubMed ID: 31102626
[TBL] [Abstract][Full Text] [Related]
19. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study.
Herden J; Eminaga O; Wille S; Weissbach L
Urol Int; 2015; 95(2):209-15. PubMed ID: 26044747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
